1. Home
  2. SNY
  3. SNY News

Latest Sanofi ADS (SNY) News on September 3, 2025

SNY

MT Newswires

18 hours ago

Thermo Fisher Scientific Completes Acquisition of Sanofi's Ridgefield Facility in New Jersey

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site
SNY

Business Wire

18 hours ago

Thermo Fisher Scientific Completes Acquisition of Sanofi’s Ridgefield, New Jersey Site

SNY

Argus Research

19 hours ago

Weekly Stock List

Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia
SNY

Zacks

2 days ago

Sanofi Gets FDA Nod for Wayrilz in Immune Thrombocytopenia

FDA approves Sanofi’s BTK inhibitor for immune thrombocytopenia
SNY

Pharmaceutical Technology

2 days ago

FDA approves Sanofi’s BTK inhibitor for immune thrombocytopenia

Norfolk Southern Corporation (NSC)’s Merger Could Suffer From CSX CEO’s Belief, Says Jim Cramer
SNY

Insider Monkey

3 days ago

Norfolk Southern Corporation (NSC)’s Merger Could Suffer From CSX CEO’s Belief, Says Jim Cramer

CSX Corporation (CSX)’s CEO Is The “Number One,” Says Jim Cramer
SNY

Insider Monkey

3 days ago

CSX Corporation (CSX)’s CEO Is The “Number One,” Says Jim Cramer

Snowflake Inc. (SNOW) Is A “Tremendous” American Company Doing Incredible Things, Says Jim Cramer
SNY

Insider Monkey

3 days ago

Snowflake Inc. (SNOW) Is A “Tremendous” American Company Doing Incredible Things, Says Jim Cramer

Burlington Stores, Inc. (BURL) Is Just “Unbelievable,” Says Jim Cramer
SNY

Insider Monkey

3 days ago

Burlington Stores, Inc. (BURL) Is Just “Unbelievable,” Says Jim Cramer

The TJX Companies, Inc. (TJX) Has “Extraordinary” Bargains, Says Jim Cramer
SNY

Insider Monkey

3 days ago

The TJX Companies, Inc. (TJX) Has “Extraordinary” Bargains, Says Jim Cramer

Loss-Making Turnium Technology Group Inc. (CVE:TTGI) Expected To Breakeven In The Medium-Term
SNY

Simply Wall St.

3 days ago

Loss-Making Turnium Technology Group Inc. (CVE:TTGI) Expected To Breakeven In The Medium-Term

Analysts Just Shaved Their EHang Holdings Limited (NASDAQ:EH) Forecasts Dramatically
SNY

Simply Wall St.

3 days ago

Analysts Just Shaved Their EHang Holdings Limited (NASDAQ:EH) Forecasts Dramatically

What Is SPX Technologies, Inc.'s (NYSE:SPXC) Share Price Doing?
SNY

Simply Wall St.

3 days ago

What Is SPX Technologies, Inc.'s (NYSE:SPXC) Share Price Doing?

Sanofi (SNY) Expands Pipeline Through Multi-Billion Acquisitions Despite Earnings Miss
SNY

Insider Monkey

3 days ago

Sanofi (SNY) Expands Pipeline Through Multi-Billion Acquisitions Despite Earnings Miss

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia
SNY

GlobeNewswire

4 days ago

Press Release: Sanofi’s Wayrilz approved in US as first BTK inhibitor for immune thrombocytopenia

Sanofi (SNY)’s Sarclisa Gets EMA Nod for Multiple Myeloma
SNY

Insider Monkey

5 days ago

Sanofi (SNY)’s Sarclisa Gets EMA Nod for Multiple Myeloma

Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA
SNY

Insider Monkey

5 days ago

Novavax, Inc. (NVAX) Wins FDA Approval for Nuvaxovid BLA

Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults
SNY

Insider Monkey

6 days ago

Novavax, Inc. (NVAX) Launches Protein-Based Vaccine for High-Risk Adults

Goldman and Citi See European Stock Rally Surviving French Drama
SNY

Bloomberg

6 days ago

Goldman and Citi See European Stock Rally Surviving French Drama

SNY

MT Newswires

6 days ago

Novavax's Nuvaxovid COVID-19 Vaccine Formula Approved by FDA

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
SNY

PR Newswire

6 days ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Amylyx drug comes up short; Sanofi names new CMO
SNY

BioPharma Dive

7 days ago

Amylyx drug comes up short; Sanofi names new CMO

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic
SNY

GlobeNewswire

7 days ago

Dyslipidemia Market Research Report 2025-2035 | Competitive Analysis of Amgen, Sanofi, Regeneron, Pfizer, Novartis, Viatris, AbbVie, AstraZeneca, Horizon Therapeutics, Esperion Therapeutic

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma
SNY

GlobeNewswire

7 days ago

Chronic Inducible Urticaria (CIndU) Market Research Report 2025-2035 | Competitive Analysis of AstraZeneca, Celldex Therapeutics, J&J, Merck, Novartis, Pfizer, Regeneron Pharma, Sanofi, Sun Pharma

SNY

Argus Research

8 days ago

The Argus High-Yield Model Portfolio

New Report Highlights Community Health Workers' Impact, Calls for Sustained Local Investment, During National CHW Awareness Week
SNY

PR Newswire

8 days ago

New Report Highlights Community Health Workers' Impact, Calls for Sustained Local Investment, During National CHW Awareness Week

Is Now the Right Moment for Sanofi After GSK Lawsuit Settlement in 2025?
SNY

Simply Wall St.

8 days ago

Is Now the Right Moment for Sanofi After GSK Lawsuit Settlement in 2025?

Sanofi (SNY) Receives Orphan Designation for Rilzabrutinib
SNY

Insider Monkey

8 days ago

Sanofi (SNY) Receives Orphan Designation for Rilzabrutinib

[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
SNY

GlobeNewswire

9 days ago

[Latest] Global Targeted Drug Delivery Market Size/Share Worth USD 39.6 Billion by 2034 at a 15.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Sanofi (ENXTPA:SAN): Revisiting Valuation as Shares Rebound After Volatile Period
SNY

Simply Wall St.

12 days ago

Sanofi (ENXTPA:SAN): Revisiting Valuation as Shares Rebound After Volatile Period

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
SNY

GlobeNewswire

13 days ago

[Latest] Global Biologics and Biosimilars Market Size/Share Worth USD 1,320.19 Billion by 2034 at a 10.42% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Leaders Come Together to Advance the Industry at Veeva Summit
SNY

PR Newswire

13 days ago

Leaders Come Together to Advance the Industry at Veeva Summit

SNY

Investing.com

14 days ago

BofA downgrades Novavax stock on vaccine uncertainty

SNY

MT Newswires

14 days ago

Novavax Faces 'Increasingly Murky' Outlook on Vaccine Uncertainties, BofA Securities Says

SNY

MT Newswires

14 days ago

European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading

LRN Corporation Wins Seven Brandon Hall Group Awards
SNY

Business Wire

14 days ago

LRN Corporation Wins Seven Brandon Hall Group Awards

SNY

MT Newswires

15 days ago

European Equities Traded in the US as American Depositary Receipts Track Higher in Tuesday Trading

Novavax Strengthens Position with Vaccine Approval and Sanofi Partnership
SNY

Insider Monkey

15 days ago

Novavax Strengthens Position with Vaccine Approval and Sanofi Partnership

Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease
SNY

PR Newswire

15 days ago

Beyfortus® (nirsevimab) approved in Singapore to protect all infants against RSV disease

Sanofi: Information concerning the total number of voting rights and shares - July 2025
SNY

GlobeNewswire

16 days ago

Sanofi: Information concerning the total number of voting rights and shares - July 2025

Sanofi receives orphan status from EMA for rilzabrutinib
SNY

Pharmaceutical Technology

16 days ago

Sanofi receives orphan status from EMA for rilzabrutinib

Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes
SNY

Pharmaceutical Technology

19 days ago

Sanofi’s Tzield secures MHRA go-ahead for type 1 diabetes

SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease
SNY

Zacks

19 days ago

SNY's Rilzabrutinib Gets EU Orphan Drug Tag for IgG4-Related Disease

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
SNY

GlobeNewswire

20 days ago

Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease

Inhibrx Reports Second Quarter 2025 Financial Results
SNY

PR Newswire

20 days ago

Inhibrx Reports Second Quarter 2025 Financial Results

Saudi Arabia Diabetes Drug Market Trends & Forecast Report 2025-2033 | New Therapeutic Agents Like SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Biosimilar Insulins Fueling Growth
SNY

GlobeNewswire

21 days ago

Saudi Arabia Diabetes Drug Market Trends & Forecast Report 2025-2033 | New Therapeutic Agents Like SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Biosimilar Insulins Fueling Growth

Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk
SNY

GlobeNewswire

21 days ago

Saudi Arabia Blood Glucose Device Market Trends and Company Analysis Report 2025-2033 Featuring Abbott Laboratories, Medtronic, Dexcom, Braun, DarioHealth, Sanofi, Bionime, and Novo Nordisk

Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates
SNY

GlobeNewswire

21 days ago

Adagene Reports Six Months 2025 Financial Results and Provides Corporate Updates

Quantified Named to 2025 Inc. 5000, One of the 50 Fastest-Growing AI Firms in the U.S.
SNY

PR Newswire

22 days ago

Quantified Named to 2025 Inc. 5000, One of the 50 Fastest-Growing AI Firms in the U.S.

Peanut Allergy Treatment Market Report 2025-2033, with Key Player Profiles for Aimmune Therapeutics, DBV Technologies, Sanofi, ALK-Abello, Prota Therapeutics, Camallergy, Aravax, and Genentech
SNY

GlobeNewswire

22 days ago

Peanut Allergy Treatment Market Report 2025-2033, with Key Player Profiles for Aimmune Therapeutics, DBV Technologies, Sanofi, ALK-Abello, Prota Therapeutics, Camallergy, Aravax, and Genentech

Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda
SNY

GlobeNewswire

22 days ago

Multiple Myeloma Market Trends and Company Analysis Report 2025-2033 Featuring BMS, Novartis, Abbvie, Sanofi, Johnson and Johnson, Baxter, Pfizer, and Takeda

SNY

Investing.com

22 days ago

Sanofi halts Praluent supply in China due to limited availability

Singapore Witnesses the Future of Logistics Unfold at GoComet's Odyssey 2025
SNY

PR Newswire

22 days ago

Singapore Witnesses the Future of Logistics Unfold at GoComet's Odyssey 2025

Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth
SNY

GlobeNewswire

23 days ago

Multiple Myeloma Global and Regional Market Analysis and Forecast Report 2025-2035 | Johnson & Johnson, Sanofi, AbbVie, Bristol-Myers Squibb, Takeda, Pfizer Drive Innovation and Growth

Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations
SNY

GlobeNewswire

23 days ago

Non-metastatic Prostate Cancer Market Analysis and Forecast, 2023-2035 | J&J, Astellas, Bristol-Myers Squibb, Pfizer, Merck, Bayer, Sanofi, Clovis, AstraZeneca, AbbVie, and Boehringer Lead Innovations

Renal Transplant Therapeutics Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | Calcineurin Inhibitors Dominate Renal Transplant Therapeutics Market
SNY

GlobeNewswire

a month ago

Renal Transplant Therapeutics Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | Calcineurin Inhibitors Dominate Renal Transplant Therapeutics Market

Pneumococcal Disease Pipeline Market Research 2025 | Therapeutic Assessments by Product Type, Stage, Administration Route, and Molecule Type
SNY

GlobeNewswire

a month ago

Pneumococcal Disease Pipeline Market Research 2025 | Therapeutic Assessments by Product Type, Stage, Administration Route, and Molecule Type

NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View
SNY

Zacks

a month ago

NVAX Stock Gains on Q2 Earnings & Sales Beat, Ups '25 Sales View

Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma
SNY

GlobeNewswire

a month ago

Influenza Vaccine Market Research Report 2025-2030 Featuring GSK, Abbott, Pfizer, AstraZeneca, Sanofi, Moderna, CSL, Emergent BioSolutions, BIKEN, Serum Institute of India, Sinovac, GC Biopharma

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda
SNY

GlobeNewswire

a month ago

United States Pharmaceutical Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Novartis, Abbvie, Johnson & Johnson, Merck, Pfizer, BMS, Sanofi, GSK, Takeda

RFK Jr’s mRNA funding halt signals “shift in US public health”
SNY

Pharmaceutical Technology

a month ago

RFK Jr’s mRNA funding halt signals “shift in US public health”

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates
SNY

GlobeNewswire

a month ago

SAB BIO Reports Second Quarter Financial Results and Highlights Company Updates

SNY

Argus Research

a month ago

Analyst Report: Sanofi SA

SNY

Argus Research

a month ago

Market Digest: SNY, DIS, GPN, ICE, SHEL, SON, SYK, MDLZ, ANET

RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down
SNY

Zacks

a month ago

RXRX Q2 Loss Wider Than Expected, Revenues Rise Y/Y, Stock Down

Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales
SNY

Benzinga

a month ago

Novavax Ups Outlook, Eyes Stronger Nuvaxovid Sales

SNY

Investing.com

a month ago

Novavax lifts 2025 revenue outlook after FDA milestone payment

Novavax raises annual revenue forecast on vaccine supply partnerships
SNY

Reuters

a month ago

Novavax raises annual revenue forecast on vaccine supply partnerships

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights
SNY

PR Newswire

a month ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

SNY

MT Newswires

a month ago

US Health Department Ending Federal mRNA Vaccine Development

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.
SNY

GlobeNewswire

a month ago

Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc.

SNY

Morningstar Research

a month ago

Analyst Report: Sanofi

BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View
SNY

Zacks

a month ago

BioMarin Beats on Q2 Earnings & Sales, Stock Gains on Raised '25 View

Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update
SNY

GlobeNewswire

a month ago

Recursion Reports Second Quarter 2025 Financial Results and Provides Business Update

SNY

Morningstar Research

a month ago

Analyst Report: BioNTech SE

Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?
SNY

Zacks

a month ago

Recursion Pharmaceuticals to Report Q2 Earnings: What's in the Cards?

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?
SNY

Zacks

a month ago

Will These 5 Pharma, Biotech Bigwigs Surpass Q2 Earnings Forecasts?

SNY

Morningstar Research

a month ago

Analyst Report: Regeneron Pharmaceuticals, Inc.

Arrowhead sells China hypertriglyceridemia candidate rights to Sanofi
SNY

Pharmaceutical Technology

a month ago

Arrowhead sells China hypertriglyceridemia candidate rights to Sanofi

Health Care Roundup: Market Talk
SNY

The Wall Street Journal

a month ago

Health Care Roundup: Market Talk

Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines
SNY

Benzinga

a month ago

Regeneron's Pipeline Hit By Catalent Delays, But Dupixent Shines

Regeneron Stock Is Rising on Earnings. This Sanofi Collaboration Is Helping.
SNY

Barrons.com

a month ago

Regeneron Stock Is Rising on Earnings. This Sanofi Collaboration Is Helping.

BioMarin Announces Appointment of Ian T. Clark to Board of Directors
SNY

PR Newswire

a month ago

BioMarin Announces Appointment of Ian T. Clark to Board of Directors

Regeneron posts better-than-expected Q2 results, downplays tariff impact
SNY

Reuters

a month ago

Regeneron posts better-than-expected Q2 results, downplays tariff impact

Reddit, Coinbase, Novo Nordisk - Trending Stocks
SNY

Yahoo Finance Video

a month ago

Reddit, Coinbase, Novo Nordisk - Trending Stocks

SNY

Investing.com

a month ago

Regeneron shares edge higher as second quarter earnings surpass estimates

SNY

MT Newswires

a month ago

Arrowhead Pharmaceuticals Unit Sells China Rights to Plozasiran to Sanofi

Regeneron Reports Second Quarter 2025 Financial and Operating Results
SNY

GlobeNewswire

a month ago

Regeneron Reports Second Quarter 2025 Financial and Operating Results

SNY

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

SNY

MT Newswires

a month ago

Sector Update: Health Care

Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas
SNY

GlobeNewswire

a month ago

Renal Failure Clinical Trials Market Landscape Report 2025 Featuring Bayer, AstraZeneca, Amgen, Sanofi, Novartis, AbbVie, Roche, Pfizer, Takeda, Astellas

SNY

MT Newswires

a month ago

Sanofi Q2 Earnings, Revenue Rise

Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA
SNY

GlobeNewswire

a month ago

Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA

Sanofi Upbeat on Sales Outlook After Faster-Than-Expected Growth
SNY

The Wall Street Journal

a month ago

Sanofi Upbeat on Sales Outlook After Faster-Than-Expected Growth

SNY

GlobeNewswire

a month ago

Press Release: Q2: double-digit sales and solid business EPS growth. 2025 sales guidance is now high single-digit growth, at upper end of range

Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components
SNY

GlobeNewswire

a month ago

Teva's Innovative Portfolio Fuels 10th Consecutive Quarter of Growth in Q2 2025; Increases 2025 Revenue Outlook for Key Innovative Products and EPS, and Reaffirms All Other Components

Infectious Disease Treatment Market Report 2025-2030 | Long-acting Injectables, Self-testing Kits, and Combination Therapies Fueling Growth
SNY

GlobeNewswire

a month ago

Infectious Disease Treatment Market Report 2025-2030 | Long-acting Injectables, Self-testing Kits, and Combination Therapies Fueling Growth

Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma
SNY

GlobeNewswire

a month ago

Press Release: Sanofi’s SAR446523, a GPRC5D monoclonal antibody, earns orphan drug designation in the US for multiple myeloma

SNY

Argus Research

a month ago

The Argus Min Vol Model Portfolio

SNY

Argus Research

a month ago

The Argus Min Vol Model Portfolio

Share on Social Networks: